Paper10659592
An in vitro chemosensitivity test for colorectal cancer using collagen-gel droplet embedded cultures.
Araki Y and 7 others. Kurume Med J, 1999. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. An in vitro chemosensitivity test for colorectal cancer using collagen-gel droplet embedded cultures. Papers, record 10659592. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10659592
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- An in vitro chemosensitivity test for colorectal cancer using collagen-gel droplet embedded cultures.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Collagen | Major topic |
| Colorectal Neoplasms | Major topic |
| Drug Screening Assays, Antitumor | Major topic |
| Humans | |
| Tumor Cells, Cultured |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31832406 | In-vitro proliferation assay with recycled ascitic cancer cells in malignant pleural mesothelioma: A case report. | World J Clin Cases | 2019 | https://conductscience.org/library/papers/31832406 | PubMed |
| 31832190 | Identification of the optimal cetuximab concentration that is effective against oral squamous cell carcinoma in collagen gel droplet embedded culture drug sensitivity testing. | Mol Clin Oncol | 2020 | https://conductscience.org/library/papers/31832190 | PubMed |
| 29285367 | Clinical study on collagen gel droplet-embedded culture drug sensitivity test for multidrug combination chemotherapy and super selective intra-arterial infusion chemoradiotherapy in oral squamous cell carcinoma. | Mol Clin Oncol | 2017 | https://conductscience.org/library/papers/29285367 | PubMed |
| 28855997 | Collagen gel droplet-embedded culture drug sensitivity testing in hard palate cancer-predicted antitumor efficacy of cetuximab: A case report. | Mol Clin Oncol | 2017 | https://conductscience.org/library/papers/28855997 | PubMed |
| 28105171 | Collagen gel droplet-embedded culture drug sensitivity testing in squamous cell carcinoma cell lines derived from human oral cancers: Optimal contact concentrations of cisplatin and fluorouracil. | Oncol Lett | 2016 | https://conductscience.org/library/papers/28105171 | PubMed |
| 22966400 | Synovial sarcoma individual chemotherapy directed by collagen gel droplet embedded culture drug sensitivity test: A case report. | Oncol Lett | 2010 | https://conductscience.org/library/papers/22966400 | PubMed |
| 16440172 | Primitive neuroectodermal tumor arising in the colon: report of a case. | Surg Today | 2006 | https://conductscience.org/library/papers/16440172 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10659592
GET https://conductscience.org/api/papers/v1/10659592/authors